View Post

FDA Warns NSAID Use After 20 Weeks of Pregnancy Could Lead to Complications

In its Drug Safety Communication, dated 10/15/2020, the Food and Drug Administration (FDA) announced that manufacturers of nonsteroidal anti-inflammatory drugs (NSAIDs) will be required to update their labeling to include warnings about potential fetal risk if women take the medications at about 20 weeks or later in their pregnancy. This is of special concern to dentistry since the use of …